Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Biomedical Chromatography : BMC
|
May 11, 2026
Untargeted Metabolomic Analysis Reveals the Mechanism Underlying Swertia mussotii Treatment on Rats With Non-Alcoholic Fatty Liver Disease Using UPLC-Q-TOF/MS
Minyue Zhang, Jiakang Sun, Shuhan Tang, et al.
Biology Direct
|
July 4, 2026
Epicatechin suppresses cancer stem-like cell phenotype and radioresistance in non-small cell lung cancer via targeting CXCL8
Tianqian Li, Hongmei Han, Meiyan Liu, et al.
Frontiers in Endocrinology
|
June 19, 2025
Effect of COVID-19 inactivated vaccine on anti-Müllerian hormone in Chinese women: a retrospective cohort study
Mingjie Bao, Leizhen Xia, Yan Ling, et al.
Journal of Separation Science
|
April 13, 2026
Identification of Novel Epimer Metabolites of Sweroside in Rats With Liquid Chromatography/Time of Flight Mass Spectrometry Combined With Picolinoyl Derivatization
Yaqi Xu, Shuhan Tang, Yidan Sun, et al.
Biomedical Chromatography : BMC
|
November 11, 2025
Untargeted Metabolomic Study on the Mechanism of Polygonatum sibiricum in Non-Alcoholic Fatty Liver Disease in Rats Using UPLC-Q-TOF/MS
Xintong Li, Fuyan Cui, Shuhan Tang, et al.
Frontiers in Pharmacology
|
October 8, 2025
Mechanism of swertiamarin and novel nitrogen-containing metabolites (<i>R</i>)-Gentiandiol and (<i>S</i>)-Gentiandiol in treating non-alcoholic fatty liver disease in rats: an untargeted metabolomics study based on UPLC-Q-TOF/MS
Yidan Sun, Fuyan Cui, Shuhan Tang, et al.
Journal of Cellular and Molecular Medicine
|
December 2, 2017
The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer
Bianfei Shao, Yixiao Feng, Hongbin Zhang, et al.
Theranostics
|
November 23, 2019
Tumor suppressive BTB/POZ zinc-finger protein ZBTB28 inhibits oncogenic BCL6/ZBTB27 signaling to maintain p53 transcription in multiple carcinogenesis
Tingxiu Xiang, Jun Tang, Lili Li, et al.
Molecular & Cellular Proteomics : MCP
|
January 31, 2013
Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies
Xijun Wang, Aihua Zhang, Ping Wang, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Biomedical Chromatography : BMC
|
May 11, 2026
Untargeted Metabolomic Analysis Reveals the Mechanism Underlying Swertia mussotii Treatment on Rats With Non-Alcoholic Fatty Liver Disease Using UPLC-Q-TOF/MS
Minyue Zhang, Jiakang Sun, Shuhan Tang, et al.
Biology Direct
|
July 4, 2026
Epicatechin suppresses cancer stem-like cell phenotype and radioresistance in non-small cell lung cancer via targeting CXCL8
Tianqian Li, Hongmei Han, Meiyan Liu, et al.
Frontiers in Endocrinology
|
June 19, 2025
Effect of COVID-19 inactivated vaccine on anti-Müllerian hormone in Chinese women: a retrospective cohort study
Mingjie Bao, Leizhen Xia, Yan Ling, et al.
Journal of Separation Science
|
April 13, 2026
Identification of Novel Epimer Metabolites of Sweroside in Rats With Liquid Chromatography/Time of Flight Mass Spectrometry Combined With Picolinoyl Derivatization
Yaqi Xu, Shuhan Tang, Yidan Sun, et al.
Biomedical Chromatography : BMC
|
November 11, 2025
Untargeted Metabolomic Study on the Mechanism of Polygonatum sibiricum in Non-Alcoholic Fatty Liver Disease in Rats Using UPLC-Q-TOF/MS
Xintong Li, Fuyan Cui, Shuhan Tang, et al.
Frontiers in Pharmacology
|
October 8, 2025
Mechanism of swertiamarin and novel nitrogen-containing metabolites (<i>R</i>)-Gentiandiol and (<i>S</i>)-Gentiandiol in treating non-alcoholic fatty liver disease in rats: an untargeted metabolomics study based on UPLC-Q-TOF/MS
Yidan Sun, Fuyan Cui, Shuhan Tang, et al.
Journal of Cellular and Molecular Medicine
|
December 2, 2017
The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer
Bianfei Shao, Yixiao Feng, Hongbin Zhang, et al.
Theranostics
|
November 23, 2019
Tumor suppressive BTB/POZ zinc-finger protein ZBTB28 inhibits oncogenic BCL6/ZBTB27 signaling to maintain p53 transcription in multiple carcinogenesis
Tingxiu Xiang, Jun Tang, Lili Li, et al.
Molecular & Cellular Proteomics : MCP
|
January 31, 2013
Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies
Xijun Wang, Aihua Zhang, Ping Wang, et al.
Page
of 4